Insights

Platform Infrastructure Valo’s Opal platform integrates human data and AI across drug discovery and development, supported by Google Cloud Platform, BigQuery, PostgreSQL, and Docker. This creates potential opportunities for cloud optimization, data governance, machine learning infrastructure, and secure data integration solutions.

Partnership Scale The expanded Novo Nordisk collaboration could cover up to 20 drug programs and includes up to $190 million in near term payments and approximately $4.6 billion in potential milestones. This scale may drive demand for collaboration tools, research workflows, data management, and clinical development services.

Leadership Changes Valo appointed a new Chief Scientific Officer in February 2026 and a new Chief Financial Officer in December 2025, bringing deep drug development and finance experience. These leadership transitions may create opportunities to engage around strategic priorities, operational systems, and scaling requirements.

Pipeline Expansion Valo is advancing programs across cardiometabolic, oncology, and neurodegenerative diseases, with a Michael J. Fox Foundation grant supporting Parkinson’s research. Organizations offering research partnerships, specialized data, laboratory capabilities, or clinical trial support may be relevant prospects.

Growth Readiness With 201 to 500 employees, reported revenue of $100 million to $250 million, and $460 million in funding, Valo has meaningful resources to support growth. Its distributed technology stack, including NetSuite, Okta, VMware, and Greenhouse, suggests potential needs in enterprise integration, identity management, infrastructure, and talent acquisition.

Similar companies to Valo Health

Valo Health Tech Stack

Valo Health uses 8 technology products and services including Docker, Google BigQuery, PostgreSQL, and more. Explore Valo Health's tech stack below.

Media & News

Valo Health's Email Address Formats

Valo Health uses at least 4 email formats:
Valo Health Email FormatsExamplePercentage
FLast@valohealth.comJDoe@valohealth.com
91%
First.Last@valohealth.comJohn.Doe@valohealth.com
7%
First@valohealth.comJohn@valohealth.com
1%
FL@valohealth.comJD@valohealth.com
1%

Frequently Asked Questions

What is Valo Health's stock symbol?

Minus sign iconPlus sign icon
Valo Health is a publicly traded company; the company's stock symbol is AVB.

What is Valo Health's official website and social media links?

Minus sign iconPlus sign icon
Valo Health's official website is valohealth.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Valo Health generate?

Minus sign iconPlus sign icon
As of October 2026, Valo Health's annual revenue is estimated to be $100M - $250M.

What is Valo Health's SIC code and NAICS code?

Minus sign iconPlus sign icon
Valo Health's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Valo Health have currently?

Minus sign iconPlus sign icon
As of October 2026, Valo Health has approximately 211 employees across 4 continents, including North America, Europe and Asia. Key team members include Chief Causal Ai Officer: C. A., Vice President, Head Of Discovery Sciences: E. S. and Executive Director: Data Science And Drug Discovery: P. B. Explore Valo Health's employee directory with LeadIQ.

What industry does Valo Health belong to?

Minus sign iconPlus sign icon
Valo Health operates in the Biotechnology Research industry.

What technology does Valo Health use?

Minus sign iconPlus sign icon
Valo Health's tech stack includes Docker, Google BigQuery, PostgreSQL, NetSuite, Okta, Google Cloud Platform, Greenhouse and VMware.

What is Valo Health's email format?

Minus sign iconPlus sign icon
Valo Health's email format typically follows the pattern of FLast@valohealth.com. Find more Valo Health email formats with LeadIQ.

How much funding has Valo Health raised to date?

Minus sign iconPlus sign icon
As of October 2026, Valo Health has raised $460M in funding. The last funding round occurred on Oct 28, 2022.

When was Valo Health founded?

Minus sign iconPlus sign icon
Valo Health was founded in 2019.
Valo Health logo

Valo Health

Biotechnology ResearchMassachusetts, United States201-500 Employees

Valo Health, based in Lexington, Massachusetts, is a biotechnology research company that uses large-scale human data and AI-driven computation to transform drug discovery and development. It seeks to unify human-centric data across the entire drug development lifecycle within a single architecture, with its Opal Computational Platform delivering an end-to-end workflow to generate actionable insights. Its initial program focus includes cardiovascular, metabolic and renal, oncology, and neurodegenerative diseases, aiming to speed discoveries and reduce development costs, time, and failure rates. 
The company collaborates with pharmaceutical partners, exemplified by a collaboration with Novo Nordisk to develop treatments for cardiometabolic diseases. In February 2026, Valo named Karin Conde-Knape as Chief Scientific Officer, reflecting leadership development at the company.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
AVB
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
201-500

Section iconFunding & Financials

  • $460M

    Valo Health has raised a total of $460M of funding over 5 rounds. Their latest funding round was raised on Oct 28, 2022 as a Series C.

  • $100M - $250M

    Valo Health's revenue is estimated to be in the range of $100M - $250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.